This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
DNA Stock Overview
Doric Nimrod Air One Limited was formerly known as Future Leasing Yield Company Limited.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Doric Nimrod Air One Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.60 |
| 52 Week High | UK£0.65 |
| 52 Week Low | UK£0.27 |
| Beta | 0 |
| 1 Month Change | -3.23% |
| 3 Month Change | 0.84% |
| 1 Year Change | 93.55% |
| 3 Year Change | -6.98% |
| 5 Year Change | -41.18% |
| Change since IPO | -42.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| DNA | GB Trade Distributors | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | -0.7% |
| 1Y | 93.5% | 10.3% | -1.8% |
Return vs Industry: DNA exceeded the UK Trade Distributors industry which returned 3.5% over the past year.
Return vs Market: DNA exceeded the UK Market which returned -3.1% over the past year.
Price Volatility
| DNA volatility | |
|---|---|
| DNA Average Weekly Movement | 1.6% |
| Trade Distributors Industry Average Movement | 3.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: DNA has not had significant price volatility in the past 3 months.
Volatility Over Time: DNA's weekly volatility has decreased from 11% to 2% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | n/a |
Doric Nimrod Air One Limited was formerly known as Future Leasing Yield Company Limited. The company is based in Channel Islands.
Doric Nimrod Air One Limited Fundamentals Summary
| DNA fundamental statistics | |
|---|---|
| Market cap | UK£25.47m |
| Earnings (TTM) | UK£0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs DNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DNA income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£0 |
| Earnings | UK£0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DNA perform over the long term?
See historical performance and comparison